Brokers are bullish on Glenmark Pharma, IDFC

16969 Investors following Glenmark. Share this News with them.

0

Like this story, share it with millions of investors on M3

Brokers are bullish on Glenmark Pharma, IDFC

Brokerage houses are bullish on Glenmark Pharma, IDFC, Yes Bank, Lupin, Cadila, Hikal, Dishman Pharma, Jubilant Organosys, Nicholas Piramal, Shasun Chemicals and Asian Hotels.

Post your opinion here

 

0

Tweet

Share on Tumblr

DSP Merrill Lynch has kept buy rating on Glenmark Pharma; it upped its target price to Rs 411

DSP Merrill Lynch has put buy rating on IDFC; with a target price of Rs 95

DSP Merrill Lynch has put buy rating on Yes Bank; with a price target of Rs 90

Edelweiss Capital has put value buy rating on Lupin

Edelweiss Capital has kept value buy rating on Cadila, Hikal

Edelweiss Capital has kept value buy rating on Dishman Pharma

Edelweiss Capital has kept value buy rating on Jubilant Organosys

Edelweiss Capital has kept value buy rating on Nicholas Piramal

Edelweiss Capital has kept value buy rating on Shasun Chemicals

ICICI Securities has kept hold rating on Ranbaxy; it has cut fair value to Rs 440

SSKI has kept outperformer rating on Bharat Forge; with a target price of Rs 435

Pranav Securities has put buy rating on Asian Hotels